Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sanofi India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500674NSE Symbol: SANOFIP/E(TTM):25.93
ISIN Demat:INE058A01010Div & Yield %:2.81EPS(TTM):160.35
Book Value(Rs):339.6135475Market Cap ( Cr.):9577.26Face Value(Rs):10
    Change Company 
( In Cr)
 Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
INCOME :      
Sales Turnover 2013.201996.102770.102956.602901.903070.60
Excise Duty0.000.000.000.000.000.00
Net Sales2013.201996.102770.102956.602901.903070.60
Other Income 116.30317.60203.50563.6089.8094.10
Stock Adjustments -60.20283.7011.10-43.10-57.50-2.30
Total Income2069.302597.402984.703477.102934.203162.40
EXPENDITURE :      
Raw Materials 919.101237.201200.701263.701196.101345.10
Power & Fuel Cost11.608.4014.3013.9023.6042.30
Employee Cost 240.20280.70405.90433.90460.80449.70
Other Manufacturing Expenses 34.2026.0074.3073.7090.3077.30
Selling and Administration Expenses 212.10192.70315.70306.90306.80433.80
Miscellaneous Expenses 82.7047.1065.9058.9095.40114.10
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1499.901792.102076.802151.002173.002462.30
Operating Profit569.40805.30907.901326.10761.20700.10
Interest 1.501.701.701.801.800.30
Gross Profit567.90803.60906.201324.30759.40699.80
Depreciation36.7036.5041.9066.7082.2099.90
Profit Before Tax531.20767.10864.301257.60677.20599.90
Tax125.80163.40245.20336.00211.00227.60
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-8.100.50-1.50-22.80-11.40-41.90
Reported Net Profit413.50603.20620.60944.40477.60414.20
Extraordinary Items -28.7714.0094.55363.33-30.63-37.98
Adjusted Net Profit442.27589.20526.05581.07508.23452.18
Adjst. below Net Profit -185.00-1.300.50-3.30-8.80-16.50
P & L Balance brought forward601.90843.201795.101694.602029.601815.10
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 384.60843.201573.00840.60803.80183.20
P & L Balance carried down445.80601.90843.201795.101694.602029.60
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1170.001670.005700.004900.003650.003490.00
Earnings Per Share-Unit Curr179.78262.26269.83410.61207.65180.09
Earnings Per Share(Adj)-Unit Curr179.78262.26269.83410.61207.65180.09
Book Value-Unit Curr374.17441.52554.70967.65921.301061.87